title: Early loss of pregnancy after intravitreal bevacizumab injection.
authors.forename: Petros
authors.initials: P
authors.lastname: Petrou
authors.forename: Ilias
authors.initials: I
authors.lastname: Georgalas
authors.forename: Georgios
authors.initials: G
authors.lastname: Giavaras
authors.forename: Eleni
authors.initials: E
authors.lastname: Anastasiou
authors.forename: Zoi
authors.initials: Z
authors.lastname: Ntana
authors.forename: Constantinos
authors.initials: C
authors.lastname: Petrou
mesh_terms: D000022:Abortion, Spontaneous / Q000139:chemically induced* / Q000175:diagnosis; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007267:Injections; D011247:Pregnancy; D011261:Pregnancy Trimester, First / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014822:Vitreous Body; D014823:Vitreous Hemorrhage / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab